Make a Splash with Summer Savings at Natural GrocersĀ®, July 10-12, 2025

Customers can enjoy sizzling deals of up to 36% off and a chance to win a Lake Tahoe getaway, plus a fun in-store scavenger hunt on Saturday, July 12 Natural Grocers®, the largest family-operated organic and natural grocery retailer in the U.S., is turning up the summer fun with its annual Splash into Savings event, […]

Domino’sĀ® Best Deal Ever is Back! Order Any Pizza with Any Toppings for $9.99

Crave-worthy secret menu pizzas you didn't know you needed are included in deal Domino's Pizza Inc. (Nasdaq: DPZ)is bringing back its “Best Deal Ever” promotion! Customers can enjoy any pizza with any toppings for $9.99 each when they order online between July 7-Aug. 3. https://mma.prnewswire.com/media/2722009/Dominos_Best_Deal_Ever_Promotion.jpg Domino's $9.99 deal includes Hand Tossed, Handmade Pan, New York

IREN June 2025 Monthly Update

(NASDAQ:IREN), SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025. June Highlights Record monthly revenue and hardware profit3 50 EH/s mid-year target achieved AI Cloud expanded with ~2.4k Blackwell GPUs $550m convertible notes offering oversubscribed US domestic

IREN June 2025 Monthly Update

IREN June 2025 Monthly Update GlobeNewswire July 07, 2025 SYDNEY, July 07, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), today published its monthly update for June 2025. June Highlights Record monthly revenue and hardware profit3 50 EH/s mid-year target achieved AI Cloud expanded with ~2.4k Blackwell

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

(NASDAQ:COGT), — Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing new benchmarks for placebo-adjusted and absolute symptomatic improvement for this patient population — — Bezuclastinib demonstrated a powerful effect on

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis GlobeNewswire July 07, 2025 — Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91

DXC Technology Appoints Professional Services Industry Veteran Ramnath Venkataraman as President of Consulting & Engineering Services

DXC Technology (NYSE:DXC), a leading Fortune 500 global technology services provider, today announced the appointment of Ramnath Venkataraman as President, Consulting & Engineering Services (CES). A distinguished leader with nearly three decades of experience at Accenture, Ramnath will report directly to DXC President and Chief Executive Officer, Raul Fernandez. “Ramnath is a world-class technology and

The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region

(NASDAQ:JYNT), – Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics – – Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise Fees over the 12 Months Ended March 31, 2025 – SCOTTSDALE, Ariz., July 07, 2025 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ:

The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region

The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region GlobeNewswire July 07, 2025 – Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics – – Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000

HIMS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Hims & Hers Health, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / July 7, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS) and certain of its officers. Class Definition This lawsuit seeks

Scroll to Top